Mutations in MLL2 (KMT2D) and TET2 were associated with inferior prognosis in ENKTL [43], and overexpression of EZH2 was associated with higher tumor cell proliferation, advanced stage, and inferior survival [38]. This evidence concerns the gene EZH2 and neoplasm.